DK3475268T3 - Forbindelser til behandling af lidelser, der er følsomme over for serotoninerg regulering styret af 5-HT1A-receptorerne - Google Patents
Forbindelser til behandling af lidelser, der er følsomme over for serotoninerg regulering styret af 5-HT1A-receptorerne Download PDFInfo
- Publication number
- DK3475268T3 DK3475268T3 DK17734043.7T DK17734043T DK3475268T3 DK 3475268 T3 DK3475268 T3 DK 3475268T3 DK 17734043 T DK17734043 T DK 17734043T DK 3475268 T3 DK3475268 T3 DK 3475268T3
- Authority
- DK
- Denmark
- Prior art keywords
- serotoninergic
- compounds
- treatment
- ht1a receptors
- disorders sensitive
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/38—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16305769.8A EP3260452A1 (en) | 2016-06-24 | 2016-06-24 | Compounds for treating disorders sensitive to serotoninergic regulation controlled by the 5-ht1a receptors |
| PCT/EP2017/065585 WO2017220799A1 (en) | 2016-06-24 | 2017-06-23 | Compounds for treating disorders sensitive to serotoninergic regulation controlled by the 5-ht1a receptors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3475268T3 true DK3475268T3 (da) | 2020-10-26 |
Family
ID=56404042
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17734043.7T DK3475268T3 (da) | 2016-06-24 | 2017-06-23 | Forbindelser til behandling af lidelser, der er følsomme over for serotoninerg regulering styret af 5-HT1A-receptorerne |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10562853B2 (da) |
| EP (2) | EP3260452A1 (da) |
| JP (1) | JP6935873B2 (da) |
| CN (1) | CN109563073B (da) |
| AU (1) | AU2017281742B2 (da) |
| CA (1) | CA3028036A1 (da) |
| DK (1) | DK3475268T3 (da) |
| ES (1) | ES2831853T3 (da) |
| WO (1) | WO2017220799A1 (da) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2702211B1 (fr) * | 1993-03-04 | 1995-06-02 | Pf Medicament | Nouveaux dérivés de la phénoxy-2 éthylamine, leur préparation et leur application en thérapeutique. |
| FR2755967B1 (fr) | 1996-11-21 | 1999-01-29 | Pf Medicament | Derives de la pyridin-2-yl-methylamine, leur procede de preparation et leur application comme medicaments |
| FR2784378B1 (fr) * | 1998-10-09 | 2000-12-29 | Pf Medicament | Nouveaux derives d'aryl-(4-fluoro-4-[(2-pyridin-2-yl- ethylamino)-methyl]-piperidin-1-yl)-methanone, leur procede de preparation et leur utilisation a titre de medicaments |
| EP2058306A1 (en) * | 2007-11-08 | 2009-05-13 | Schwarz Pharma Ag | Heteroaryl-substituted 2-pyridinyl-methylamine derivatives |
| PL395470A1 (pl) * | 2011-06-29 | 2013-01-07 | Adamed Spólka Z Ograniczona Odpowiedzialnoscia | Sulfonamidowe pochodne amin alicyklicznych do leczenia chorób osrodkowego ukladu nerwowego |
-
2016
- 2016-06-24 EP EP16305769.8A patent/EP3260452A1/en not_active Withdrawn
-
2017
- 2017-06-23 CN CN201780038390.3A patent/CN109563073B/zh active Active
- 2017-06-23 ES ES17734043T patent/ES2831853T3/es active Active
- 2017-06-23 US US16/312,847 patent/US10562853B2/en active Active
- 2017-06-23 WO PCT/EP2017/065585 patent/WO2017220799A1/en unknown
- 2017-06-23 AU AU2017281742A patent/AU2017281742B2/en active Active
- 2017-06-23 CA CA3028036A patent/CA3028036A1/en active Pending
- 2017-06-23 EP EP17734043.7A patent/EP3475268B9/en active Active
- 2017-06-23 DK DK17734043.7T patent/DK3475268T3/da active
- 2017-06-23 JP JP2019520488A patent/JP6935873B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20190194132A1 (en) | 2019-06-27 |
| EP3475268B9 (en) | 2021-04-21 |
| CA3028036A1 (en) | 2017-12-28 |
| ES2831853T3 (es) | 2021-06-09 |
| US10562853B2 (en) | 2020-02-18 |
| CN109563073A (zh) | 2019-04-02 |
| JP6935873B2 (ja) | 2021-09-15 |
| EP3475268B1 (en) | 2020-08-19 |
| JP2019519615A (ja) | 2019-07-11 |
| EP3260452A1 (en) | 2017-12-27 |
| EP3475268A1 (en) | 2019-05-01 |
| CN109563073B (zh) | 2021-12-07 |
| WO2017220799A1 (en) | 2017-12-28 |
| AU2017281742B2 (en) | 2021-01-07 |
| AU2017281742A1 (en) | 2019-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA46188A (fr) | Composés indole substitués par pyridyle | |
| DK3119397T3 (da) | Heterocykliske forbindelser til anvendelse i behandling af PI3K-gamma-medierede lidelser | |
| DK3498278T3 (da) | Forbindelser til behandling af sygdomme relateret til DUX4-ekspression | |
| MA40774A (fr) | Dérivés de diaryle-urée en tant qu'inhibiteurs de kinase p38 | |
| DK3497081T3 (da) | Fremgangsmåde til fremstilling af 4-ammonium-2,2,6,6-tetraalkylpiperidinylsalte | |
| DK3305317T3 (da) | Forbindelser til behandling af neuropsykiatriske forstyrrelser | |
| DK3279202T3 (da) | Krystal af 3,5-disubstitueret benzenalkynylforbindelse | |
| DK3390407T3 (da) | Fremgangsmåder til fremstilling af heterocykliske 1,3-benzodioxolforbindelser | |
| DK3692039T3 (da) | Enantiomerer af substituerede thiazoler som antivirale forbindelser | |
| EA201790982A1 (ru) | Синтез копанлисиба и его дигидрохлорида | |
| DK3097085T3 (da) | Benzoxazinonderivater til behandling af hudsygdomme | |
| DK3210973T3 (da) | Heteroarylforbindelser til behandling af oftalmiske sygdomme | |
| DK3191513T3 (da) | Anvendelse af reslizumab til behandling af moderat til svær eosinofil astma | |
| DK3573620T3 (da) | Sammensætninger til behandling af hypertension | |
| DK3458467T3 (da) | Fremgangsmåde til 6,7-alfa-epoxidering af steroid-4,6-diener | |
| DK3515455T3 (da) | Forbindelser til behandling af lidelser i lipoproteinmetabolismen | |
| DK3724173T3 (da) | Forbindelser til behandling af neuromuskulære lidelser | |
| DK3578562T3 (da) | L-valinatamidbenzoxaborolderivater til behandling af parasitiske sygdomme | |
| DK3432895T3 (da) | Blodpladepelletlysat til anvendelse til behandling af neurologiske forstyrrelser | |
| DK3130592T3 (da) | ANALOGER AF 4H-PYRAZOLO[1,5-á]BENZIMIDAZOL-FORBINDELSER SOM PARPINHIBITORER | |
| BR112016029510A2 (pt) | métodos para a preparação de um composto, e, composto intermediário. | |
| DK3302573T3 (da) | Sammensætning til behandlingen af hjernelæsioner | |
| DK3662925T3 (da) | Sammensætning, der omfatter fsh, til behandling af infertilitet | |
| DK3452465T3 (da) | Substituerede 2,4-diaminoquinolinderivater til anvendelse til behandling af proliferative sygdomme | |
| DK3339387T3 (da) | Forbindelser på basis af addukter med isocyanater til belægningssammensætninger |